Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 801

1.

Metallothionein Expression in Horses With Chronic Liver Disease and Its Correlation With Ki-67 Immunoreactivity.

Verhoef JNC, Allen AL, Harding JCS, Al-Dissi AN.

Vet Pathol. 2018 Sep;55(5):703-710. doi: 10.1177/0300985818777802. Epub 2018 Jun 4.

PMID:
29865992
2.

Perspectives of Dutch Physiotherapists on Self-Management Support: A Q-Methodology Study.

Van Wely L, Boiten JC, Verhoef J, Eijckelhof BH, Van Hooft SM, Van Staa A, Roelofs PD.

Physiother Theory Pract. 2019 Apr;35(4):318-326. doi: 10.1080/09593985.2018.1443182. Epub 2018 Feb 23.

PMID:
29474105
3.

The Contribution of Anthroposophic Medicine to Self-Management: An Exploration of Concepts, Evidence, and Patient Perspectives.

Baars EW, Koster EB, Verhoef J.

Complement Med Res. 2017;24(4):225-231. doi: 10.1159/000478981. Epub 2017 Aug 15. Review.

PMID:
28803238
4.

Live-cell Imaging of Platelet Degranulation and Secretion Under Flow.

Barendrecht AD, Verhoef JJF, Pignatelli S, Pasterkamp G, Heijnen HFG, Maas C.

J Vis Exp. 2017 Jul 10;(125). doi: 10.3791/55658.

5.

Within-Host Selection of Drug Resistance in a Mouse Model Reveals Dose-Dependent Selection of Atovaquone Resistance Mutations.

Nuralitha S, Murdiyarso LS, Siregar JE, Syafruddin D, Roelands J, Verhoef J, Hoepelman AIM, Marzuki S.

Antimicrob Agents Chemother. 2017 Apr 24;61(5). pii: e01867-16. doi: 10.1128/AAC.01867-16. Print 2017 May.

6.

Polyphosphate nanoparticles on the platelet surface trigger contact system activation.

Verhoef JJ, Barendrecht AD, Nickel KF, Dijkxhoorn K, Kenne E, Labberton L, McCarty OJ, Schiffelers R, Heijnen HF, Hendrickx AP, Schellekens H, Fens MH, de Maat S, Renné T, Maas C.

Blood. 2017 Mar 23;129(12):1707-1717. doi: 10.1182/blood-2016-08-734988. Epub 2017 Jan 3.

7.

Iron nanomedicines induce Toll-like receptor activation, cytokine production and complement activation.

Verhoef JJF, de Groot AM, van Moorsel M, Ritsema J, Beztsinna N, Maas C, Schellekens H.

Biomaterials. 2017 Mar;119:68-77. doi: 10.1016/j.biomaterials.2016.11.025. Epub 2016 Nov 21.

PMID:
28002754
8.

Docosahexaenoic acid liposomes for targeting chronic inflammatory diseases and cancer: an in vitro assessment.

Alaarg A, Jordan NY, Verhoef JJ, Metselaar JM, Storm G, Kok RJ.

Int J Nanomedicine. 2016 Oct 5;11:5027-5040. eCollection 2016.

9.

A novel oral iron-complex formulation: Encapsulation of hemin in polymeric micelles and its in vitro absorption.

Span K, Verhoef JJF, Hunt H, van Nostrum CF, Brinks V, Schellekens H, Hennink WE.

Eur J Pharm Biopharm. 2016 Nov;108:226-234. doi: 10.1016/j.ejpb.2016.09.002. Epub 2016 Sep 4.

PMID:
27600943
10.

Within-Host Selection of Drug Resistance in a Mouse Model of Repeated Incomplete Malaria Treatment: Comparison between Atovaquone and Pyrimethamine.

Nuralitha S, Siregar JE, Syafruddin D, Roelands J, Verhoef J, Hoepelman AI, Marzuki S.

Antimicrob Agents Chemother. 2015 Oct 26;60(1):258-63. doi: 10.1128/AAC.00538-15. Print 2016 Jan.

11.

Interventions for fatigue in Parkinson's disease.

Elbers RG, Verhoef J, van Wegen EE, Berendse HW, Kwakkel G.

Cochrane Database Syst Rev. 2015 Oct 8;(10):CD010925. doi: 10.1002/14651858.CD010925.pub2. Review.

PMID:
26447539
12.

Genogeography and Immune Epitope Characteristics of Hepatitis B Virus Genotype C Reveals Two Distinct Types: Asian and Papua-Pacific.

Thedja MD, Muljono DH, Ie SI, Sidarta E, Turyadi, Verhoef J, Marzuki S.

PLoS One. 2015 Jul 10;10(7):e0132533. doi: 10.1371/journal.pone.0132533. eCollection 2015.

13.

Potential induction of anti-PEG antibodies and complement activation toward PEGylated therapeutics.

Verhoef JJ, Carpenter JF, Anchordoquy TJ, Schellekens H.

Drug Discov Today. 2014 Dec;19(12):1945-52. doi: 10.1016/j.drudis.2014.08.015. Epub 2014 Sep 7. Review.

PMID:
25205349
14.

Questioning the Use of PEGylation for Drug Delivery.

Verhoef JJ, Anchordoquy TJ.

Drug Deliv Transl Res. 2013 Dec;3(6):499-503.

15.

Development of work participation in young adults with cerebral palsy: a longitudinal study.

Verhoef JA, Bramsen I, Miedema HS, Stam HJ, Roebroeck ME; Transition and Lifespan Research Group South West Netherlands.

J Rehabil Med. 2014 Jul;46(7):648-55. doi: 10.2340/16501977-1832.

16.

Effectiveness of an interactive postgraduate educational intervention with patient participation on the adherence to a physiotherapy guideline for hip and knee osteoarthritis: a randomised controlled trial.

Peter W, van der Wees PJ, Verhoef J, de Jong Z, van Bodegom-Vos L, Hilberdink WK, Fiocco M, Vliet Vlieland TP.

Disabil Rehabil. 2015;37(3):274-82. doi: 10.3109/09638288.2014.913708. Epub 2014 Apr 29.

PMID:
24773119
17.

Impact of fatigue on health-related quality of life in patients with Parkinson's disease: a prospective study.

Elbers RG, van Wegen EE, Verhoef J, Kwakkel G.

Clin Rehabil. 2014 Mar;28(3):300-11. doi: 10.1177/0269215513503355. Epub 2013 Oct 10.

PMID:
24113725
18.

Functional disability in patients with rheumatoid arthritis admitted for multidisciplinary rehabilitation from 1992 to 2009.

Meesters J, Verhoef J, Tijhuis G, Vliet Vlieland T.

Rheumatology (Oxford). 2013 Oct;52(10):1879-83. doi: 10.1093/rheumatology/ket232. Epub 2013 Jul 16.

PMID:
23861533
19.

Improved occupational performance of young adults with a physical disability after a vocational rehabilitation intervention.

Verhoef JA, Roebroeck ME, van Schaardenburgh N, Floothuis MC, Miedema HS.

J Occup Rehabil. 2014 Mar;24(1):42-51. doi: 10.1007/s10926-013-9446-9.

PMID:
23624979
20.

A new intervention to improve work participation of young adults with physical disabilities: a feasibility study.

Verhoef JA, Miedema HS, Van Meeteren J, Stam HJ, Roebroeck ME.

Dev Med Child Neurol. 2013 Aug;55(8):722-8. doi: 10.1111/dmcn.12158. Epub 2013 Apr 28.

21.

Is gait speed a valid measure to predict community ambulation in patients with Parkinson's disease?

Elbers RG, van Wegen EE, Verhoef J, Kwakkel G.

J Rehabil Med. 2013 Apr;45(4):370-5. doi: 10.2340/16501977-1123.

22.

Quality indicators for physiotherapy care in hip and knee osteoarthritis: development and clinimetric properties.

Peter WF, van der Wees PJ, Hendriks EJ, de Bie RA, Verhoef J, de Jong Z, van Bodegom-Vos L, Hilberdink WK, Vliet Vlieland TP.

Musculoskeletal Care. 2013 Dec;11(4):193-202. doi: 10.1002/msc.1041. Epub 2012 Dec 21.

PMID:
23280718
23.

Postgraduate education to increase adherence to a Dutch physiotherapy practice guideline for hip and knee OA: a randomized controlled trial.

Peter WF, van der Wees PJ, Verhoef J, de Jong Z, van Bodegom-Vos L, Hilberdink WK, Fiocco M, Vliet Vlieland TP.

Rheumatology (Oxford). 2013 Feb;52(2):368-75. doi: 10.1093/rheumatology/kes264. Epub 2012 Oct 11.

PMID:
23065316
24.

Using the work limitations questionnaire in patients with a chronic condition in the Netherlands.

Verhoef JA, Miedema HS, Bramsen I, Roebroeck ME.

J Occup Environ Med. 2012 Oct;54(10):1293-9. doi: 10.1097/JOM.0b013e31825cb68d.

PMID:
22995808
25.

A qualitative study of barriers to the implementation of a rheumatoid arthritis guideline among generalist and specialist physical therapists.

van Bodegom-Vos L, Verhoef J, Dickmann M, Kleijn M, van Vliet I, Hurkmans E, van der Wees P, Vliet Vlieland T.

Phys Ther. 2012 Oct;92(10):1292-305. doi: 10.2522/ptj.20110097. Epub 2012 Jun 21.

PMID:
22723432
26.

Physical therapists' management of rheumatoid arthritis: results of a Dutch survey.

Hurkmans EJ, Li L, Verhoef J, Vliet Vlieland TP.

Musculoskeletal Care. 2012 Sep;10(3):142-8. doi: 10.1002/msc.1011. Epub 2012 Apr 11.

PMID:
22496051
27.
28.

Reliability and structural validity of the Multidimensional Fatigue Inventory (MFI) in patients with idiopathic Parkinson's disease.

Elbers RG, van Wegen EE, Verhoef J, Kwakkel G.

Parkinsonism Relat Disord. 2012 Jun;18(5):532-6. doi: 10.1016/j.parkreldis.2012.01.024. Epub 2012 Feb 22.

29.

Self-report fatigue questionnaires in multiple sclerosis, Parkinson's disease and stroke: a systematic review of measurement properties.

Elbers RG, Rietberg MB, van Wegen EE, Verhoef J, Kramer SF, Terwee CB, Kwakkel G.

Qual Life Res. 2012 Aug;21(6):925-44. doi: 10.1007/s11136-011-0009-2. Epub 2011 Oct 20. Review.

30.

Physiotherapy in rheumatoid arthritis: development of a practice guideline.

Hurkmans EJ, van der Giesen FJ, Bloo H, Boonman DC, van der Esch M, Fluit M, Hilberdink WK, Peter WF, van der Stegen HP, Veerman EA, Verhoef J, Vermeulen HM, Hendriks HM, Schoones JW, Vliet Vlieland TP; Guideline Steering Committee.

Acta Reumatol Port. 2011 Apr-Jun;36(2):146-58.

31.

Differences in spontaneously reported hypersensitivity and serious adverse events for intravenous iron preparations: comparison of Europe and North America.

Bailie GR, Hörl WH, Verhoef JJ.

Arzneimittelforschung. 2011;61(5):267-75. doi: 10.1055/s-0031-1296198.

PMID:
21755809
32.

Neutralization of Neisseria meningitidis outer membrane vesicles.

Vida A, Troelstra A, Antal-Szalmás P, van Bommel TJ, Verheul AF, Verhoef J, van Kessel KP, van Strijp JA.

Inflamm Res. 2011 Sep;60(9):801-5. doi: 10.1007/s00011-011-0344-3. Epub 2011 May 24.

PMID:
21607761
33.

Ethnogeographical structure of hepatitis B virus genotype distribution in Indonesia and discovery of a new subgenotype, B9.

Thedja MD, Muljono DH, Nurainy N, Sukowati CH, Verhoef J, Marzuki S.

Arch Virol. 2011 May;156(5):855-68. doi: 10.1007/s00705-011-0926-y. Epub 2011 Feb 12.

34.

Colonization and transmission of meticillin-susceptible and meticillin-resistant Staphylococcus aureus in a murine nasal colonization model.

Bloemendaal AL, Vriens MR, Jansen WT, Borel Rinkes IH, Verhoef J, Fluit AC.

J Med Microbiol. 2011 Jun;60(Pt 6):812-6. doi: 10.1099/jmm.0.027532-0. Epub 2011 Feb 11.

PMID:
21317194
35.

Fatigue of zirconia and dental bridge geometry: Design implications.

Quinn GD, Studart AR, Hebert C, VerHoef JR, Arola D.

Dent Mater. 2010 Dec;26(12):1133-6. doi: 10.1016/j.dental.2010.07.014. Epub 2010 Sep 1.

36.

Evolution in quantum leaps: multiple combinatorial transfers of HPI and other genetic modules in Enterobacteriaceae.

Paauw A, Leverstein-van Hall MA, Verhoef J, Fluit AC.

PLoS One. 2010 Jan 13;5(1):e8662. doi: 10.1371/journal.pone.0008662.

37.

Yersiniabactin reduces the respiratory oxidative stress response of innate immune cells.

Paauw A, Leverstein-van Hall MA, van Kessel KP, Verhoef J, Fluit AC.

PLoS One. 2009 Dec 29;4(12):e8240. doi: 10.1371/journal.pone.0008240.

38.

Validity and responsiveness of the World Health Organization Disability Assessment Schedule II to assess disability in rheumatoid arthritis patients.

Meesters JJ, Verhoef J, Liem IS, Putter H, Vliet Vlieland TP.

Rheumatology (Oxford). 2010 Feb;49(2):326-33. doi: 10.1093/rheumatology/kep369. Epub 2009 Dec 1.

PMID:
19952091
39.

Colonization with multiple Staphylococcus aureus strains among patients in European intensive care units.

Bloemendaal AL, Fluit AC, Jansen WT, Vriens MR, Ferry T, Amorim JM, Pascual A, Stefani S, Papaparaskevas J, Borel Rinkes IH, Verhoef J.

Infect Control Hosp Epidemiol. 2009 Sep;30(9):918-20. doi: 10.1086/605640. No abstract available.

40.

Identification of resistance and virulence factors in an epidemic Enterobacter hormaechei outbreak strain.

Paauw A, Caspers MP, Leverstein-van Hall MA, Schuren FH, Montijn RC, Verhoef J, Fluit AC.

Microbiology. 2009 May;155(Pt 5):1478-88. doi: 10.1099/mic.0.024828-0. Epub 2009 Apr 16.

PMID:
19372158
41.

Acquisition and cross-transmission of Staphylococcus aureus in European intensive care units.

Bloemendaal AL, Fluit AC, Jansen WM, Vriens MR, Ferry T, Argaud L, Amorim JM, Resende AC, Pascual A, López-Cerero L, Stefani S, Castiglione G, Evangelopoulou P, Tsiplakou S, Rinkes IH, Verhoef J.

Infect Control Hosp Epidemiol. 2009 Feb;30(2):117-24. doi: 10.1086/593126.

42.

Current Challenge in Consumer Health Informatics: Bridging the Gap between Access to Information and Information Understanding.

Alpay L, Verhoef J, Xie B, Te'eni D, Zwetsloot-Schonk JH.

Biomed Inform Insights. 2009 Jan 1;2(1):1-10.

43.

Characterization of Dutch Staphylococcus aureus from bovine mastitis using a Multiple Locus Variable Number Tandem Repeat Analysis.

Ikawaty R, Brouwer EC, Jansen MD, van Duijkeren E, Mevius D, Verhoef J, Fluit AC.

Vet Microbiol. 2009 May 12;136(3-4):277-84. doi: 10.1016/j.vetmic.2008.10.034. Epub 2008 Nov 13.

PMID:
19101101
44.

Mannose binding lectin plays a crucial role in innate immunity against yeast by enhanced complement activation and enhanced uptake of polymorphonuclear cells.

van Asbeck EC, Hoepelman AI, Scharringa J, Herpers BL, Verhoef J.

BMC Microbiol. 2008 Dec 18;8:229. doi: 10.1186/1471-2180-8-229.

45.

The echinocandin caspofungin impairs the innate immune mechanism against Candida parapsilosis.

van Asbeck EC, Hoepelman AI, Scharringa J, Verhoef J.

Int J Antimicrob Agents. 2009 Jan;33(1):21-6. doi: 10.1016/j.ijantimicag.2008.06.013. Epub 2008 Sep 6.

PMID:
18774697
46.

Surveillance study of the susceptibility of Haemophilus influenzae to various antibacterial agents in Europe and Canada.

Jansen WT, Verel A, Beitsma M, Verhoef J, Milatovic D.

Curr Med Res Opin. 2008 Oct;24(10):2853-61. doi: 10.1185/03007990802381505 . Epub 2008 Aug 28.

PMID:
18759995
47.

Validity and responsiveness of the Rehabilitation Activities Profile (RAP) in patients with rheumatoid arthritis.

Verhoef J, Toussaint PJ, Putter H, Zwetsloot-Schonk JH, Vliet Vlieland TP.

Clin Rehabil. 2008 Sep;22(9):788-800. doi: 10.1177/0269215508091204.

PMID:
18728132
48.

Genomic diversity within the Enterobacter cloacae complex.

Paauw A, Caspers MP, Schuren FH, Leverstein-van Hall MA, Delétoile A, Montijn RC, Verhoef J, Fluit AC.

PLoS One. 2008 Aug 21;3(8):e3018. doi: 10.1371/journal.pone.0003018.

49.

Modelling genetic regulation of growth and form in a branching sponge.

Kaandorp JA, Blom JG, Verhoef J, Filatov M, Postma M, Müller WE.

Proc Biol Sci. 2008 Nov 22;275(1651):2569-75. doi: 10.1098/rspb.2008.0746.

50.

Novel multiple-locus variable-number tandem-repeat analysis method for rapid molecular typing of human Staphylococcus aureus.

Ikawaty R, Willems RJ, Box AT, Verhoef J, Fluit AC.

J Clin Microbiol. 2008 Sep;46(9):3147-51. doi: 10.1128/JCM.00861-08. Epub 2008 Jul 23.

Supplemental Content

Loading ...
Support Center